A new study found difamilast ointment 1% to be safe and efficacious in the treatment of atopic dermatitis (AD).
Dupilumab-induced ocular surface disease more frequently associated with AD, study shows
According to a new study, dupilumab-induced ocular surface disease (DIOSD) appears to occur more frequently in patients with atopic dermatitis (AD) than in patients with other conditions being treated with the biologic.
HealthMinute.TV 